Aprameya Engineering (NSE:APRAMEYA) ROCE %: 15.36% (As of Mar. 2026)


NSE:APRAMEYA Aprameya Engineering Ltd NSE:APRAMEYA
41 GF Score
Price ₹151.00
! 6 Warning Signs
View Full Analysis

What is Aprameya Engineering ROCE %?

Aprameya Engineering NSE:APRAMEYA -1.15% 41 ROCE % is 15.36% as of Mar. 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aprameya Engineering's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.36%.


Aprameya Engineering  (NSE:APRAMEYA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Aprameya Engineering ROCE % Related Terms


Aprameya Engineering ROCE % Historical Data

* Premium members only.

The historical data trend for Aprameya Engineering's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprameya Engineering ROCE % Chart

Aprameya Engineering Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 151.18 29.50 18.51 46.76 15.36

Aprameya Engineering Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE % Get a 7-Day Free Trial 151.18 29.50 18.51 46.76 15.36
NSE:APRAMEYA
41GF Score
Aprameya Engineering Ltd NSE:APRAMEYA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aprameya Engineering ROCE % Calculation

Aprameya Engineering's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=109.304/( ( (1439.61 - 734.34) + (822.682 - 104.968) )/ 2 )
=109.304/( (705.27+717.714)/ 2 )
=109.304/711.492
=15.36 %

Aprameya Engineering's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=109.304/( ( (1439.61 - 734.34) + (822.682 - 104.968) )/ 2 )
=109.304/( ( 705.27 + 717.714 )/ 2 )
=109.304/711.492
=15.36 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.36% mean?
Aprameya Engineering (NSE:APRAMEYA) has a ROCE % of 15.36% as of Mar. 2026.
Is Aprameya Engineering's ROCE % too high?
Aprameya Engineering's current ROCE % is 15.36%. The Medical Devices & Instruments industry median ROCE % is 2.23. Aprameya Engineering's value of 15.36% is 588.8% above this industry median. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's ROCE % compare to ISRG and BDX?
Aprameya Engineering's ROCE % of 15.36% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Aprameya Engineering's value of 15.36% is 588.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current ROCE % of 15.36% is 588.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current ROCE % is 15.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current ROCE % of 15.36%. The current ROCE % is 15.36% and 588.8% above the Medical Devices & Instruments industry median of 2.23. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current ROCE % is 15.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprameya Engineering Business Description

Address 908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score

Get the complete analysis for NSE:APRAMEYA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹151.00
Price